Browse by category

GENEVA: No difference in 30-day morbidity and mortality of SG, RYGB and OAGB patients

There is no significant difference in the 30-day morbidity and mortality of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and...

There is a significant and early loss of fat-free mass (FFM) in patients with severe obesity who undergo bariatric surgery, which is not...

New research from RCSI University of Medicine and Health Sciences has demonstrated the significant role that an irregular body clock...

The surge on the numbers of obesity in Brazil - especially after the COVID-19 pandemic - and the new treatments to bring back quality of...

Patients with morbid obesity undergoing general surgery may benefit from having general surgery at a high volume bariatric centres,...

Bariatric surgery has an overall 0.08% mortality rate with no statistically significant difference between overall, 30-day, 90-day or...

Study investigators of the Multi-Center Endoscopic Sleeve Gastroplasty (ESG) Randomized Interventional Trial (MERIT) have announced that...

Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en- Y Gastric Bypass (LRYGB) may have better health-related quality of life...

Access to bariatric surgery increased by 31% annually for lower-income Medicaid-covered and uninsured white adults age 26 to 64 but not...

Sleeve gastrectomy is safer than gastric bypass for Medicare patients after five years, researchers led by University of Michigan Health...